Delivery Order SPE2DB20D1109-SPE2DB23FP23S
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $12,143.49 for the supply of RINVOQ ER 30 MG TABLET UU 30S medical products. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, on December 21, 2023, with an ultimate completion date of December 22, 2023. The contract is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $24,219.52 for the supply of RINVOQ ER 15 MG TABLET. The contract was awarded on December 12, 2022 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 13, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,714.94 for the supply of RINVOQ ER 15 MG TABLET products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major healthcare provider for the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a delivery order valued at $19,678.26 for the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,976.63 for the pharmaceutical product RINVOQ ER 15 MG TABLET. The award, which has a completion date of May 11, 2022, is a firm fixed-price contract and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $17,211.95 for the supply of 4562967074 ! RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of December 4, 2023 and was awarded on December 1, 2023. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the Department of Defense and other federal...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,367.67 for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $8,383.92 for the pharmaceutical product RINVOQ ER 15 MG TABLET. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense's healthcare needs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,532.29 Firm Fixed Price delivery order covers the supply of RINVOQ ER 30 MG TABLET 30S, a specialty pharmaceutical product. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $7,976.78 for the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP23SDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,797.67. The award, issued by the Defense Logistics Agency (DLA), is for the supply of the pharmaceutical product RINVOQ ER 15 MG TABLET. The contract has a firm fixed-price pricing type and an ultimate completion date of June 1, 2023. Amerisourcebergen is a major pharmaceutical distributor that serves as a key supplier to various government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 5/31/23 |